BMRN Price / Book | BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC (BMRN) Price / Book

2026-09-03: Price/Book Ratio 2.03.
2026-06-30: Price/Book Ratio 1.75.
2026-03-31: Price/Book Ratio 1.76.
2025-12-31: Price/Book Ratio 1.88.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.03
2026-06-30	1.75
2026-03-31	1.76
2025-12-31	1.88
2025-09-30	1.72
2025-06-30	1.75
2025-03-31	2.34
2024-12-31	2.22
2024-09-30	2.47
2024-06-30	2.96
2024-03-31	3.27
2023-12-31	3.67
2023-09-30	3.4
2023-06-30	3.41
2023-03-31	3.92
2022-12-31	4.19
2022-09-30	3.45
2022-06-30	3.42
2022-03-31	3.25
2021-12-31	3.81
2021-09-30	3.33
2021-06-30	3.61
2021-03-31	3.31
2020-12-31	3.89
2020-09-30	3.41
2020-06-30	6.9
2020-03-31	4.71
2019-12-31	4.87
2019-09-30	3.94
2019-06-30	5.19
2019-03-31	5.42
2018-12-31	5.11
2018-09-30	5.92
2018-06-30	5.8
2018-03-31	5.1
2017-12-31	5.58
2017-09-30	5.81
2017-06-30	5.69
2017-03-31	5.49
2016-12-31	5.17
2016-09-30	6
2016-06-30	6.62
2016-03-31	5.84
2015-12-31	7.05
2015-09-30	7.41
2015-06-30	9.34
2015-03-31	8.24
2014-12-31	8.82
2014-09-30	7.05
2014-06-30	6.26
2014-03-31	6.81
2013-12-31	7.53
2013-09-30	8.04
2013-06-30	6.2
2013-03-31	6.92
2012-12-31	6.09
2012-09-30	4.91
2012-06-30	4.88
2012-03-31	5.13
2011-12-31	5.11
2011-09-30	4.7
2011-06-30	4.15
2011-03-31	3.87
2010-12-31	4.15
2010-09-30	3.91
2010-06-30	5.33
2009-12-31	5.89

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05